Provided by Tiger Trade Technology Pte. Ltd.

Eledon Pharmaceuticals, Inc.

2.62
-0.0300-1.13%
Post-market: 2.710.0900+3.44%19:44 EDT
Volume:828.99K
Turnover:2.17M
Market Cap:212.90M
PE:-2.66
High:2.68
Open:2.67
Low:2.57
Close:2.65
52wk High:4.60
52wk Low:1.35
Shares:81.26M
Float Shares:74.57M
Volume Ratio:1.27
T/O Rate:1.11%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.9867
EPS(LYR):-0.5566
ROE:-110.71%
ROA:-39.02%
PB:2.96
PE(LYR):-4.71

Loading ...

Aug 11, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Jun 23, 2022

Major Issues Report

8-K - Current report
May 31, 2022

Major Issues Report

8-K - Current report
May 12, 2022

Major Issues Report

8-K - Current report
May 12, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Mar 24, 2022

Major Issues Report

8-K - Current report
Mar 24, 2022

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 14, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 11, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 10, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Jan 28, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Jan 26, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Jan 13, 2022

Major Issues Report

8-K - Current report
Jan 11, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Jan 11, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Aug 19, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Jul 09, 2021

Statement Of Changes In Beneficial Ownership

3 - Initial statement of beneficial ownership of securities
Jul 02, 2021

Major Issues Report

8-K - Current report
Jun 16, 2021

Major Issues Report

8-K - Current report
May 18, 2021

Correspondence

CORRESP [Cover] - Correspondence